NTP-LEVOFLOXACIN DIN 02358670
Health Canada record
| Active ingredient(s) | LEVOFLOXACIN 750 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01MA12 LEVOFLOXACIN |
| Original market date | |
| Current status date | 06-Aug-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEVOFLOXACIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02537079 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | HIKMA CANADA LIMITED | Solution | LEVOFLOXACIN 5 MG | Marketed |
| 02460122 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | STERIMAX INC | Solution | LEVOFLOXACIN 5 MG | Approved |
| 02314932 | LEVOFLOXACIN IN 5% DEXTROSE INJECTION | PFIZER CANADA ULC | Solution | LEVOFLOXACIN 5 MG | Marketed |
| 02361035 | AVA-LEVOFLOXACIN | AVANSTRA INC | Tablet | LEVOFLOXACIN 500 MG | Cancelled Post Market |
| 02361027 | AVA-LEVOFLOXACIN | AVANSTRA INC | Tablet | LEVOFLOXACIN 250 MG | Cancelled Post Market |
| 02236841 | LEVAQUIN | JANSSEN INC | Tablet | LEVOFLOXACIN 250 MG | Cancelled Post Market |
| 02236840 | LEVAQUIN 25MG/ML | JANSSEN INC | Solution | LEVOFLOXACIN 25 MG | Cancelled Post Market |
| 02236842 | LEVAQUIN 500MG | JANSSEN INC | Tablet | LEVOFLOXACIN 500 MG | Cancelled Post Market |
| 02236839 | LEVAQUIN 5MG/ML | JANSSEN INC | Solution | LEVOFLOXACIN 5 MG | Cancelled Post Market |
| 02246804 | LEVAQUIN 750MG | JANSSEN INC | Tablet | LEVOFLOXACIN 750 MG | Cancelled Post Market |
| 02358662 | NTP-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN 500 MG | Cancelled Pre Market |
| 02358654 | NTP-LEVOFLOXACIN | TEVA CANADA LIMITED | Tablet | LEVOFLOXACIN 250 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14809 | 2013-10-09 | Abbreviated New Drug Submission (ANDS) | MERGER/BUYOUT |
| 11866 | 2010-11-12 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |
International API supply for LEVOFLOXACIN
23 active FDA Drug Master Files.
Request a quote for NTP-LEVOFLOXACIN